Your research is complex, but your biosourcing shouldn’t be. Get the exact materials you need to execute your research, study, or trial.
Spend more time on discovery and innovation, less time shopping for biomaterials.
Your research is complex, but your biosourcing shouldn’t be. Get the exact materials you need to execute your research, study, or trial.
Spend more time on discovery and innovation, less time shopping for biomaterials.
MART-1, also known as Melan-A, is a protein expressed in a high proportion of melanoma cells. It is recognized by tumor-infiltrating T lymphocytes (TILs) from melanoma patients. One of the immunodominant peptides — wild-type MART-126-35 (EAAGIGILTV) and its analog, which contains an alanine to leucine substitution at position 27, MART-126-35, 27L (ELAGIGILTV) — have been used in several melanoma vaccine trials.
Ignyte Bio offers anti-MART-1-specific CD8+ T cells generated against the analog peptide MART-126-35, 27L. . For more information, please read our blog on Ignyte Bio’s MART-1 specific T cells.
From custom human immune cell product development to consulting services for assay development, study design, and biomaterials selection — you need us at your bench.
What can we develop together?
Get the cells and services you need to optimize your resources.
Easily source well-characterized immune cell products to accelerate your clients’ projects.
Partner with us to expand your offerings.
We’re scientists, not salespeople – we won’t try to sell you something you don’t need, but we will try to develop something you never imagined possible.